Welcome to the HIV Specimen Cryorepository

The Global HIV Vaccine Research Cryorepository (GHRC) is an advanced HIV Specimen repository where samples obtained from specific Hiv cohorts like early responders or from tests of vaccine candidates are collected and shared in controlled low-temperature conditions for long-term preservation and for sharing among collaborating HIV research laboratories.

GHRC has been established on behalf of the Bill & Melinda Gates Foundation to support the global HIV vaccine research by collecting and offering cryo-preserved HIV specimens of relevance for vaccine development to researchers from the Collaboration for Aids Vaccine Discovery (CAVD).

GHRC also conducts research to develop novel procedures for optimized sample processing and cryo-preservation. The reagents generated, key information about these reagents, as well as all new technology developed by the GHRC are made available for HIV / AIDS vaccine development. This will help to ensure that the vaccine candidates will be genetically, immunologically and biologically relevant.

News & Press

02-Dec-10 20:08

Now online 
Our brand new Video Gallery

08-Aug-12 15:19

WHO-UNAIDS Guidelines

At the annual meeting of the GHRC consortium in December 2011 it was proposed that the new edition of the Guidelines should be a collaborative effort between WHO and the GHRC consortium. To ensure that the Guidelines include all aspects of HIV vaccine research, an advisory group of experts representing different fields met in a 3-day meeting at the premises of the FhG-IBMT in Sulzbach on 18-20 June 2012.